The PE Ratio as of November 2024 (TTM) for Edgewise Therapeutics, Inc. (EWTX) is -21.47

According to Edgewise Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -21.47. This represents a change of 63.79% compared to the average of -13.11 of the last 4 quarters.

Edgewise Therapeutics, Inc. (EWTX) Historical PE Ratio (quarterly & annually)

How has EWTX PE Ratio performed in the past?

The mean historical PE Ratio of Edgewise Therapeutics, Inc. over the last ten years is -59.65. The current -21.47 PE Ratio has changed 3.50% with respect to the historical average. Over the past ten years (40 quarters), EWTX's PE Ratio was at its highest in in the March 2021 quarter at -1.86. The PE Ratio was at its lowest in in the March 2020 quarter at -47.89.

Edgewise Therapeutics, Inc. (EWTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Edgewise Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Edgewise Therapeutics, Inc. (EWTX) Average PE Ratio

How has EWTX PE Ratio performed in the past?

The current PE Ratio of Edgewise Therapeutics, Inc. (EWTX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Edgewise Therapeutics, Inc. (EWTX) PE Ratio vs. Peers

How is EWTX’s PE Ratio compared to its peers?

Edgewise Therapeutics, Inc.’s PE Ratio is less than Century Therapeutics, Inc. (-0.79), less than C4 Therapeutics, Inc. (-2.80), less than Mineralys Therapeutics, Inc. (-4.06), less than Cullinan Oncology, Inc. (-5.10), less than Talaris Therapeutics, Inc. (-0.53), less than Adicet Bio, Inc. (-0.69), less than Vor Biopharma Inc. (-0.48), less than Ikena Oncology, Inc. (-1.38), less than Design Therapeutics, Inc. (-6.66), less than Xilio Therapeutics, Inc. (-0.90), less than Eliem Therapeutics, Inc. (-2.42), less than Werewolf Therapeutics, Inc. (-1.34), less than Decibel Therapeutics, Inc. (-1.95), less than Celcuity Inc. (-6.01), less than TCR2 Therapeutics Inc. (-0.38), less than Revolution Medicines, Inc. (-16.70), less than Black Diamond Therapeutics, Inc. (-1.96), less than Atreca, Inc. (-0.06), less than Passage Bio, Inc. (-0.45),

Build a custom stock screener for Edgewise Therapeutics, Inc. (EWTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Edgewise Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Edgewise Therapeutics, Inc. (EWTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Edgewise Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.